344
Views
27
CrossRef citations to date
0
Altmetric
Commentary

Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines

, , , , &
Pages 147-149 | Received 02 Nov 2016, Accepted 03 Jan 2017, Published online: 24 Jan 2017

References

  • Etheridge ML, Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. 2013. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 9:1–14.
  • Jamei M. 2016. Recent advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a transition from academic curiosity to regulatory acceptance. Curr Pharmacol Rep 2:161–9.
  • Khorasani AA, Weaver JL, Salvador-Morales C. 2014. Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques. Int J Nanomed 9:5729–51.
  • Lipinski CA. 2016. Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev 101:34–41.
  • Marchese Robinson RL, Cronin MTD, Richarz A-N, Rallo R. 2015. An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology. Beilstein J Nanotechnol 6:1978–99.
  • Marchese Robinson RL, Lynch I, Peijnenburg W, Rumble J, Klaessig F, Marquardt C, et al. 2016. How should the completeness and quality of curated nanomaterial data be evaluated? Nanoscale 8:9919–43.
  • Min Y, Caster JM, Eblan MJ, Wang AZ. 2015. Clinical translation of nanomedicine. Chemical Rev 115:11147–90.
  • Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–53.
  • Rumble J, Freiman S. 2012. Describing nanomaterials: meeting the needs of diverse data communities. Data Sci J 11:ASMD1–6.
  • Stark WJ. 2011. Nanoparticles in Biological Systems. Angew Chem Int Ed 50:1242–58.
  • Stefaniak AB, Hackley VA, Roebben G, Ehara K, Hankin S, Postek MT, et al. 2013. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 7:1325–37.
  • Svenson S. 2012. Clinical translation of nanomedicines. Curr Opin Solid State and Mater Sci 16:287–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.